ORCHPHARMA Share Price Performance
₹979.05
295.50 (43.23%)
2.0% overvalued intrinsic discount
₹960.00
Fair Value
Price ₹979.05
AnalystConsensusTarget ₹960.00
Fair Value₹960.00
Share Pricen/a
Analysis Article • Jun 01
Orchid Pharma Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
ORCHPHARMA Community Narratives
AN
Fair Value
·Fair Value ₹960 2.0% overvalued intrinsic discount
New Licensing Partnerships And Manufacturing Facilities Will Build Future Resilience
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
New Licensing Partnerships And Manufacturing Facilities Will Build Future Resilience
Key Takeaways Global expansion and licensing of innovative antibiotics strengthen Orchid's market position and support long-term revenue and margin growth. Enhanced manufacturing and product focus boost operational efficiency, margin resilience, and earnings stability amid industry consolidation and rising healthcare needs.Read more
AN
₹960
2.0% overvalued intrinsic discount
Fair Value
Revenue
38.4% p.a.
Profit Margin
10.9%
Future PE
27.97x
Price in 2028
₹1.36k
Trending Discussion
Recently Updated Narratives
AN
New Licensing Partnerships And Manufacturing Facilities Will Build Future Resilience
Fair Value: ₹960 2.0% overvalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Orchid Pharma Limited Key Details
About ORCHPHARMA
- Founded
- 1992
- Employees
- 736
- CEO
- WebsiteView website
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.
